Invasive Cancer Incidence and Survival — United States, 2013

Henley, S. Jane; Singh, Simple D.; King, Jessica; Wilson, Reda J.; O’Neil, Mary Elizabeth; Ryerson, A. Blythe

doi:10.15585/mmwr.mm6603a1

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Invasive Cancer Incidence and Survival — United States, 2013

Published Date:

Jan 27 2017

Publisher's site:

http://dx.doi.org/10.15585/mmwr.mm6603a1 New Site Icon

Source:

MMWR Morb Mortal Wkly Rep. 66(3):69-75.

Language:

English

[PDF-399.31 KB]

Details:

Alternative Title:

MMWR Morb Mortal Wkly Rep

Personal Author:

Henley, S. Jane ; Singh, Simple D. ; King, Jessica ; Wilson, Reda J. ; O’Neil, Mary Elizabeth ; ... More ▼

Description:

Although cancer represents many heterogeneous diseases, some cancer types share common risk factors. For example, conclusive evidence links cancer at multiple sites with tobacco use, alcohol use, human papillomavirus (HPV) infection, excess body weight, and physical inactivity (1,2). To monitor changes in cancer incidence and assess progress toward achieving Healthy People 2020 objectives,* CDC analyzed data from the U.S. Cancer Statistics (USCS) data set for 2013, the most recent year for which incidence and survival data are available. In 2013, a total of 1,559,130 invasive cancers were reported to cancer registries in the United States (excluding Nevada), for an annual age-adjusted incidence rate of 439 cases per 100,000 persons. Cancer incidence rates were higher among males (479) than females (413), highest among blacks (444), and ranged by state from 364 (New Mexico) to 512 (Kentucky) per 100,000 persons (359 in Puerto Rico). The proportion of persons with cancer who survived ≥5 years after diagnosis was 67%. This proportion was the same for males and females (67%), but lower among blacks (62%) than among whites (67%). Cancer surveillance data are key to cancer epidemiologic and clinical outcomes research, program planning and monitoring, resource allocation, and state and federal appropriations accountability.

Subject:

[+]

Pubmed ID:

28125576

Pubmed Central ID:

PMC5724910

Document Type:

Journal Article

Place as Subject:

United States

Collection(s):

Morbidity and Mortality Weekly Report (MMWR)

Main Document Checksum:

[+]

Supporting Files:

mm6603a1.nxml

text/xml

No Related Documents.

You May Also Like:

Estimating health benefits and cost-savings for achieving the Healthy People 2020 objective of reducing invasive colorectal cancer☆

Personal Author:

Hung, Mei-Chuan; Ekwueme, Donatus U.; White, Arica; Rim, Sun Hee; King, Jessica B.; Wang, Jung-Der; Chang, Su-Hsin;

Published Date:

Sep 28 2017

Source:

Prev Med. 106:38-44.

Description:

This study aims to quantify the aggregate potential life-years (LYs) saved and healthcare cost-savings if the Healthy People 2020 objective were met to reduce invasive colorectal cancer (CRC) incidence by 15%. We identified patients (n=886,380) diagn...

File Type:

[PDF - 598.68 KB]
Racial/ethnicity disparities in invasive breast cancer among younger and older women: An analysis using multiple measures of population health

Personal Author:

Hung, Mei-Chuan; Ekwueme, Donatus U.; Rim, Sun Hee; White, Arica;

Published Date:

Oct 25 2016

Source:

Cancer Epidemiol. 45:112-118.

Description:

IntroductionFew studies have examined age and racial/ethnic disparities in invasive breast cancer among younger (age 15–44 years) vs. older (age 45–64 years) women. This study estimates disparities in breast cancer among younger compared with old...

File Type:

[PDF - 507.05 KB]
Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000–2010

Personal Author:

Parise, Carol A; Caggiano, Vincent;

Published Date:

Oct 02 2013

Source:

BMC Cancer. 2013; 13:449.

Description:

BackgroundRacial disparities in breast cancer survival have been well documented. This study examines the association of race/ethnicity and socioeconomic status (SES) on breast cancer-specific mortality in a large population of women with invasive br...

File Type:

[PDF - 221.02 KB]
Human Papillomavirus Genotype Prevalence in Invasive Penile Cancers from a Registry-Based United States Population

Personal Author:

Hernandez, Brenda Y.; Goodman, Marc T.; Unger, Elizabeth R.; Steinau, Martin; Powers, Amy; Lynch, Charles F.; Cozen, Wendy; Saber, Maria Sibug; Peters, Edward S.; Wilkinson, Edward J.; Copeland, Glenn; Hopenhayn, Claudia; Huang, Youjie; Watson, Meg; Altekruse, Sean F.; Lyu, Christopher; Saraiya, Mona;

Corporate Authors:

The HPV Typing of Cancer Workgroup

Published Date:

Feb 05 2014

Source:

Front Oncol. 2014; 4.

Description:

Human papillomavirus (HPV) is estimated to play an etiologic role in 40-50% of penile cancers worldwide. Estimates of HPV prevalence in U.S. penile cancer cases are limited.|HPV DNA was evaluated in tumor tissue from 79 invasive penile cancer patient...

File Type:

[PDF - 534.13 KB]
Invasive Cancer Incidence and Survival — United States, 2011

Personal Author:

Henley, S. Jane; Singh, Simple D.; King, Jessica; Wilson, Reda; O’Neil, Mary Elizabeth; Ryerson, A. Blythe;

Published Date:

Mar 13 2015

Source:

MMWR Morb Mortal Wkly Rep. 2015; 64(9):237-242.

Description:

Because of improvements in early detection and treatment of cancer, the proportion of persons with cancer who survive ≥5 years after diagnosis has increased. To assess progress toward achieving Healthy People 2020 objectives,* CDC analyzed data fro...

File Type:

[PDF - 419.52 KB]